Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Starting soon · Not applicable

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.

Key facts

Study ID

NCT07040501

Run by

Case Comprehensive Cancer Center

People needed

50

Starts

2026-06-01

Expected to finish

2027-01-01

Last updated by the study team

2026-04-30

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must be >18 years or age
• Participants must have received a prostate biopsy at Cleveland Clinic main campus within the last 30 days, and have not received follow-up on their pathology results
• Participants must be willing to attend an in-person follow-up to review their pathology
• Participants must be English speaking
• Participants must provide informed consent

You may not qualify if…

• Participants who do not meet the inclusion criteria, as stated above

Where it is running

• Case Comprehensive Cancer Center, Cleveland Clinic Glickman Urologic Institute — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.